A comparison of lansoprazole and ranitidine in the treatment of erosive oesophagitis

Alimentary Pharmacology & Therapeutics

Volumn 9, Issue 1, 1995, Pages 25-31

  ROBINSON, M ^a   SAHBA, B ^a   AVNER, D ^a   JHALA, N ^a   GRESKI ROSE P A ^b   JENNINGS, D E ^b  

^a Multicentre Investigational Group ^*  (United States)

^b TAP Pharmaceuticals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LANSOPRAZOLE; PLACEBO; RANITIDINE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERANCE; ENDOSCOPY; EROSIVE GASTRITIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REFLUX ESOPHAGITIS; SIDE EFFECT;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADMINISTRATION, ORAL; ALCOHOL DRINKING; ANTI-ULCER AGENTS; CAFFEINE; DOUBLE-BLIND METHOD; DRUG EVALUATION; ESOPHAGITIS, PEPTIC; FEMALE; GASTROSCOPY; H(+)-K(+)-EXCHANGING ATPASE; HUMANS; LONGITUDINAL STUDIES; MALE; OMEPRAZOLE; RANITIDINE; SMOKING;

EID: 0028955775     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.1995.tb00347.x     Document Type: Review

References (19)

1. Pathogenesis of reflux esophagitis
2. Role of acid and pepsin in acute experimental esophagitis
3. Medical therapy for gastro‐oesophageal reflux
4. Daytime gastro‐oesophageal reflux is important in oesophagitis
5. Twenty‐four‐hour intragastric acidity in duodenal ulcer patients during dosing with placebo, and 150 mg ranitidine twice or four times daily
6. Twenty‐four‐hour intragastric acidity and plasma gastrin concentration before and during treatment with either ranitidine or omeprazole
7. Effect of lansoprazole on intragastric pH: Comparison between morning and evening dosing
8. Omeprazole: Overview and opinion
9. Appropriate acid suppression for the management of gastrooesophageal reflux disease
10. Lansoprazole: A review of its pharmacodynamic and pharmacokinetic properties and its therapeutic efficacy in acid–related disorders
11. +‐ATPase inhibitor, on gastric pH and serum gastrin
12. Histopathological classification of nonantral gastric endocrine growths in man
13. Ranitidine for erosive esophagitis: a double‐blind placebo‐controlled study
14. 2‐blockers, antacids and prokinetic drugs
15. Comparison of omeprazole with ranitidine in the treatment of reflux esophagitis
16. Drug‐induced changes in plasma gastrin concentration
17. Twenty‐four‐hour intragastric acidity and plasma gastrin concentration in healthy subjects and patients with duodenal or gastric ulcer or pernicious anaemia
18. 24‐hour intragastric acidity and plasma gastrin after omeprazole treatment and after proximal gastric vagotomy in duodenal ulcer patients
19. Effects of hypergastrinemia and hypochlorhydria on GI cell structure and function